Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic ...

A new strain of multidrug resistant Pseudocitrobacter bacteria has been identified by researchers. The novel strain was resistant to seven different classes of antibiotics, according to the data, ...

Gut microbiota by-products circulate in the bloodstream, regulating host physiological processes including immunity, metabolism and brain functions. Scientists from the Institut Pasteur (a partner ...

Researchers from a couple of American universities are corralling bacteria with shear force, giving the tiny organisms renewed purpose. As a result, biodegradable bacterial cellulose can be ...

Disrupting quorum sensing in Enterococcus faecalis can backfire, causing larger biofilms, higher antibiotic tolerance, and ...

Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. A consortium led by researchers at Helmholtz Munich, with participation from Ludwig ...

Researchers have discovered that a key bacterial protein, CsrA, gathers in a droplet-like structure inside cells to control when and how bacteria activate their disease-causing genes. This newly ...